Supplementary Table S2 from Phase II Trial of Pembrolizumab and Anti-CD3 X Anti-HER2 Bispecific Antibody-Armed Activated T Cells in Metastatic Castration-Resistant Prostate Cancer
crossref（2023）
Key words
Metastatic Prostate Cancer,T Cell Therapy
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined